tiprankstipranks
Trending News
More News >
Lepu Biopharma Co. Ltd. Class H (HK:2157)
:2157
Hong Kong Market

Lepu Biopharma Co. Ltd. Class H (2157) Similar Stocks

Compare
3 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Lepu Biopharma Co. Ltd. Class H
HK$5.34
HK$9.93B
-48.49
99.25%
1 Buy
0 Hold
0 Sell
Moderate Buy
Ascletis Pharma, Inc.
HK$12.95
HK$14.50B
-45.44
496.77%
0 Buy
1 Hold
0 Sell
Hold
Keymed Biosciences, Inc.
HK$62.80
HK$15.32B
-52.74
55.28%
4 Buy
0 Hold
0 Sell
Strong Buy
CARsgen Therapeutics Holdings Ltd.
HK$15.33
HK$9.02B
-15.42
58.86%
0 Buy
0 Hold
0 Sell
Moderate Buy
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
HK$27.04
HK$11.23B
75.05
225.93%
ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H
HK$6.21
HK$5.31B
-7.48
1.14%
0 Buy
0 Hold
0 Sell
Hold

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:2157
Lepu Biopharma Co. Ltd. Class H
5.28
2.20
71.43%
HK:1672
Ascletis Pharma, Inc.
12.95
10.57
444.12%
HK:2162
Keymed Biosciences, Inc.
53.65
19.95
59.20%
HK:2171
CARsgen Therapeutics Holdings Ltd.
15.33
6.13
66.63%
HK:2315
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
26.40
18.65
240.65%
HK:1541
ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H
6.21
0.15
2.48%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts